Position in EPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,068,000
New position
Shares Held
700,000
first reported quarter
Ownership
1.07%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#10
of 54 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Redmile Group, LLC holds $1,432,283,191 across 31 Biotechnology names. EPRX ranks #26 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
9,066,621 | $445,715,088 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
673,505 | $173,979,811 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
4,164,120 | $135,583,747 | |
| 4 | IMNM |
Immunome Inc.
|
5,558,885 | $121,572,814 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
7,732,808 | $119,858,524 | |
| 6 | ANNX |
Annexon, Inc.
|
14,549,768 | $80,605,714 | |
| 7 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $36,610,577 | |
| 8 | STTK |
Shattuck Labs, Inc.
|
5,539,724 | $35,620,425 |
All Filings in EPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,068,000 | 700,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||